Belič A - Search Results

1

Modular Serial Flow Through device for pulsed electric field treatment of the liquid samples.

Kandušer M, Belič A, Čorović S, Škrjanc I. Kandušer M, et al. Among authors: belic a. Sci Rep. 2017 Aug 14;7(1):8115. doi: 10.1038/s41598-017-08620-8. Sci Rep. 2017. PMID: 28808315 Free PMC article.

2

Gripping-force identification using EEG and phase-demodulation approach.

Logar V, Skrjanc I, Belic A, Karba R, Brezan S, Koritnik B, Zidar J. Logar V, et al. Among authors: belic a. Neurosci Res. 2008 Apr;60(4):389-96. doi: 10.1016/j.neures.2007.12.009. Epub 2007 Dec 31. Neurosci Res. 2008. PMID: 18243387

3

Identification of the phase code in an EEG during gripping-force tasks: a possible alternative approach to the development of the brain-computer interfaces.

Logar V, Skrjanc I, Belic A, Brezan S, Koritnik B, Zidar J. Logar V, et al. Among authors: belic a. Artif Intell Med. 2008 Sep;44(1):41-9. doi: 10.1016/j.artmed.2008.06.003. Epub 2008 Jul 26. Artif Intell Med. 2008. PMID: 18657956 Clinical Trial.

4

Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models.

Belic A, Skrjanc I, Bozic DZ, Karba R, Vrecer F. Belic A, et al. Eur J Pharm Biopharm. 2009 Sep;73(1):172-8. doi: 10.1016/j.ejpb.2009.05.005. Epub 2009 May 22. Eur J Pharm Biopharm. 2009. PMID: 19465122

5

Tableting process optimisation with the application of fuzzy models.

Belic A, Skrjanc I, Bozic DZ, Vrecer F. Belic A, et al. Int J Pharm. 2010 Apr 15;389(1-2):86-93. doi: 10.1016/j.ijpharm.2010.01.023. Epub 2010 Jan 22. Int J Pharm. 2010. PMID: 20096760

6

Cytochrome P450 metabolism of the post-lanosterol intermediates explains enigmas of cholesterol synthesis.

Ačimovič J, Goyal S, Košir R, Goličnik M, Perše M, Belič A, Urlep Ž, Guengerich FP, Rozman D. Ačimovič J, et al. Among authors: belic a. Sci Rep. 2016 Jun 23;6:28462. doi: 10.1038/srep28462. Sci Rep. 2016. PMID: 27334049 Free PMC article.

7

Kinetic model of drug distribution in the urinary bladder wall following intravesical instillation.

Grabnar I, Bogataj M, Belic A, Logar V, Karba R, Mrhar A. Grabnar I, et al. Among authors: belic a. Int J Pharm. 2006 Sep 28;322(1-2):52-9. doi: 10.1016/j.ijpharm.2006.05.026. Epub 2006 May 19. Int J Pharm. 2006. PMID: 16806751

8

The role of pharmacokinetic modelling and computer simulation in drug formulation design.

Grabnar I, Belic A, Mrhar A, Karba R. Grabnar I, et al. Among authors: belic a. Comput Biol Med. 1998 Jul;28(4):365-76. doi: 10.1016/s0010-4825(98)00020-1. Comput Biol Med. 1998. PMID: 9805197

9

Influence of fever on the pharmacokinetics of ciprofloxacin.

Beovic B, Mrhar A, Karba R, Zupancic T, Grabnar I, Belic A, Marolt-Gomiscek M. Beovic B, et al. Among authors: belic a. Int J Antimicrob Agents. 1999 Jan;11(1):81-5. doi: 10.1016/s0924-8579(98)00061-2. Int J Antimicrob Agents. 1999. PMID: 10075283

10

Influence of fever on cefazolin pharmacokinetics.

Beović B, Mrhar A, Karba R, Zupancic T, Grabnar I, Belic A, Marolt-Gomiscek M. Beović B, et al. Among authors: belic a. J Chemother. 1999 Feb;11(1):40-5. doi: 10.1179/joc.1999.11.1.40. J Chemother. 1999. PMID: 10078779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page